| IAS WEBSITE EDITORIAL BOARD |
 Editor-in-Chief |
Scott M. Grundy, MD, PhD
Dallas, TX, USA |
 Associate Editors |
Stefano Bellosta
Milan, Italy
Emanuela Folco
Milan, Italy
Ann Jackson
Houston, TX, USA |
 Website Editors |
Gianpaolo Bagnato
Milan, Italy
Annamaria Scimone
Milan, Italy
Mandi Wong
Dallas, TX, USA |
| JOIN THE MAILING LIST |
 To receive the IAS e-Newsletter and IAS Literature e-Newsletter, please send an email to ias@utsouthwestern.edu
 To be removed for the IAS Mailing List, please send an email to ias@utsouthwestern.edu and put "REMOVE" in the subject
|
| RECOMMEND AN ARTICLE ON ATHEROSCLEROSIS |
 To recommend a recent article on atherosclerosis, please send an email to: ias@utsouthwestern.edu
Journal Information:
Date, Author, Title, Journal
Your Information:
Name, Credentials
Your article may be featured in an upcoming issue of the IAS Literature
e-Newsletter. |
|
The International Atherosclerosis Society Literaure
e-Newsletter is a monthly compilation of the latest
research articles on atherosclerosis.
Apo/Lipoprotein |
| Oxidation of chylomicron remnant-like particles inhibits their uptake by THP-1 macrophages by apolipoprotein E-dependent processes.
Authors: Bejta F, Moore EH, Avella M, Gough PJ, Suckling KE, Botham KM.
Journal: Biochim Biophys Acta. 2007 Jul;1771(7):901-10. Epub 2007 May 3.
View Abstract
Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study).
Authors: Frontini MG, Srinivasan SR, Xu JH, Tang R, Bond MG, Berenson G.
Journal: Am J Cardiol. 2007 Jul 1;100(1):64-8. Epub 2007 May 11.
View Abstract
(1)H NMR investigation on interaction between ibuprofen and lipoproteins.
Authors: Lan W, Zhu H, Zhou Z, Ye C, Liu M.
Journal: Chem Phys Lipids. 2007 Aug;148(2):105-111. Epub 2007 May 10.
View Abstract
Analysis of modified apolipoprotein B-100 structures formed in oxidized low-density lipoprotein using LC-MS/MS.
Authors: Obama T, Kato R, Masuda Y, Takahashi K, Aiuchi T, Itabe H.
Journal: Proteomics. 2007 Jul;7(13):2132-41.
View Abstract
Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo.
Authors: Puranik R, Bao S, Nobecourt E, Nicholls SJ, Dusting GJ, Barter PJ, Celermajer DS, Rye KA.
Journal: Atherosclerosis. 2007 Jun 22; [Epub ahead of print]
View Abstract
Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?
Authors: Schaefer EJ, Asztalos BF.
Journal: Curr Opin Cardiol. 2007 Jul;22(4):373-8.
View Abstract
(1)H NMR at 800MHz facilitates detailed phospholipid follow-up during atherogenic modifications in low density lipoproteins.
Authors: Soininen P, Oorni K, Maaheimo H, Laatikainen R, Kovanen PT, Kaski K, Ala-Korpela M.
Journal: Biochem Biophys Res Commun. 2007 Aug 17;360(1):290-4. Epub 2007 Jun 18.
View Abstract
POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease.
Authors: Uehara Y, Tsuboi Y, Zhang B, Miura SI, Baba Y, Higuchi MA, Yamada T, Rye KA, Saku K.
Journal: Atherosclerosis. 2007 Jun 7; [Epub ahead of print]
View Abstract
Lipoprotein-associated phospholipase A2 predicts 5-year cardiac mortality independently of established risk factors and adds prognostic information in patients with low and medium high-sensitivity C-reactive protein (the ludwigshafen risk and cardiovascular health study).
Authors: Winkler K, Hoffmann MM, Winkelmann BR, Friedrich I, Schafer G, Seelhorst U, Wellnitz B, Wieland H, Boehm BO, Marz W.
Journal: Clin Chem. 2007 Aug;53(8):1440-7. Epub 2007 Jun 15.
View Abstract
High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.
Authors: Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark MJ, Szeto WL, Watson AD, Lusis AJ, Berliner JA.
Journal: Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1346-53. Epub 2007 Mar 22.
View Abstract
Secretion of Apolipoprotein E From Macrophages Occurs via a Protein Kinase A and Calcium-Dependent Pathway Along the Microtubule Network.
Kockx M, Guo DL, Huby T, Lesnik P, Kay J, Sabaretnam T, Jary E, Hill M, Gaus K, Chapman J, Stow JL, Jessup W, Kritharides L.
Circ Res. 2007 Jul 27; [Epub ahead of print]
View Abstract |
> Back to Top
 Biomarkers |
The relative impact of different measures of adiposity on
markers of early atherosclerosis.
Authors: Stamatelopoulos KS, Lekakis JP, Vamvakou G,
Katsichti P, Protogerou A, Revela I, Karatzi K, Alevizaki M,
Zakopoulos
N, Papamichael
CM.
Journal: Int J Cardiol. 2007 Jul 10;119(2):139-46. Epub 2006
Oct 11.
View Abstract
Association of blood pressure and fitness with levels of atherosclerotic
risk markers pre-exercise and post-exercise.
Authors: von Kanel R, Hong S, Pung MA, Mills PJ.
Journal: Am J Hypertens. 2007 Jun;20(6):670-5.
View Abstract
Differential association of hemoglobin with pro-inflammatory high density
lipoproteins in atherogenic/hyperlipidemic mice - a novel biomarker of
atherosclerosis.
Authors: Watanabe J, Chou KJ, Liao JC, Miao Y, Meng HH, Ge
H, Grijalva V, Hama S, Kozak K, Buga G, Whitelegge JP,
Lee TD, Farias-Eisner
R, Navab M, Fogelman
AM, Reddy
ST.
Journal: J Biol Chem. 2007 Jun 7; [Epub ahead of print]
View Abstract |
> Back to Top
Diabetes |
Serum
levels of sRAGE, the soluble form of receptor for advanced
glycation end products, are associated with inflammatory
markers in patients with type 2 diabetes.
Authors: Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura
Y, Matsui T, Yoshida T, Imaizumi T.
Journal: Mol Med. 2007 Mar-Apr;13(3-4):185-9.
View
Abstract
Effects of insulin dependence on inflammatory process, thrombotic
mechanisms and endothelial function, in patients with type 2 diabetes
mellitus and coronary
atherosclerosis.
Authors: Antoniades C, Tousoulis D, Marinou K, Papageorgiou N, Bosinakou
E, Tsioufis C, Stefanadi E, Latsios G, Tentolouris C, Siasos G, Stefanadis
C.
Journal: Clin Cardiol. 2007 Jun;30(6):295-300.
View Abstract
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding
protein aP2.
Authors: Furuhashi M, Tuncman G, Gorgun CZ, Makowski
L, Atsumi G, Vaillancourt E, Kono K, Babaev
VR, Fazio S, Linton MF, Sulsky
R, Robl JA, Parker
RA, Hotamisligil
GS.
Journal: Nature. 2007 Jun 21;447(7147):959-65. Epub 2007 Jun
6.
View Abstract
Dyslipidemia in type 2 diabetes mellitus.
Authors: Gadi R, Samaha FF.
Journal: Curr Diab Rep. 2007 Jun;7(3):228-34.
View Abstract |
> Back to Top
 Drug Therapy |
Understanding eNOS for pharmacological modulation of endothelial function: a translational view.
Authors: Braam B, Verhaar MC.
Journal: Curr Pharm Des. 2007;13(17):1727-40. Review.
View Abstract Caveolae and caveolin-1: novel potential targets for
the treatment of cardiovascular disease.
Authors: Frank PG, Hassan GS, Rodriguez-Feo JA, Lisanti MP.
Journal: Curr Pharm Des. 2007;13(17):1761-9. Review.
View Abstract
Growth factor therapy in atherosclerotic disease-friend
or foe.
Authors: Hoefer IE, Timmers L, Piek JJ.
Journal: Curr Pharm Des. 2007;13(17):1803-10. Review.
View Abstract
Vascular benefits of angiotensin receptor blockers.
Author: Voors AA.
Journal: Expert Opin Investig Drugs. 2007 Jul;16(7):987-97.
Review.
View
Abstract
Rosuvastatin restores superoxide dismutase expression
and inhibits accumulation of oxidized LDL in the aortic arch
of obese dyslipidemic mice.
Verreth W, De Keyzer
D, Davey PC, Geeraert B, Mertens A, Herregods
MC, Smith G, Desjardins F, Balligand JL, Holvoet
P. Br J Pharmacol. 2007 Jun;151(3):347-55.
Epub 2007 Mar 26.
View
Abstract |
> Back to Top
| Epidemiology |
Prevalence, recognition and treatment of cardiovascular risk factors in outpatients
with atherothrombosis in Israel.
Authors: Barski L, Porath A, Novack V, Jotkowitz A.
Journal: Isr Med Assoc J. 2007 May;9(5):376-9.
View Abstract
Association between cardiorespiratory fitness and prevalence
of carotid atherosclerosis among men with hypertension.
Authors: Jae SY, Carnethon MR, Heffernan KS, Choi YH, Lee
MK, Fernhall B.
Journal: Am Heart J. 2007 Jun;153(6):1001-5.
View Abstract
Whole-grain intake and carotid artery atherosclerosis in a multiethnic
cohort: the Insulin Resistance Atherosclerosis Study.
Authors: Mellen PB, Liese AD, Tooze JA, Vitolins MZ,
Wagenknecht LE, Herrington DM.
Journal: Am J Clin Nutr. 2007 Jun;85(6):1495-502.
View Abstract
Overview of dietary influences on atherosclerotic vascular disease:
epidemiology and prevention.
Authors: Thomas GN, Cheung
BM, Ho SY, Macfarlane DJ, Deng HB, McGhee SM, Woo J, Lam TH,
Tomlinson
B.
Journal: Cardiovasc Hematol Disord Drug Targets. 2007 Jun;7(2):87-97.
Review.
View Abstract |
> Back to Top
Genetics of Cardiovascular Disease |
What
is the relationship among atherosclerosis markers, apolipoprotein
E polymorphism and dementia?
Authors: Altamura C, Squitti R, Pasqualetti P, Tibuzzi F, Silvestrini
M, Ventriglia MC, Cassetta E, Rossini PM, Vernieri F.
Journal: Eur J Neurol. 2007 Jun;14(6):679-82.
View Abstract
Genetic deletion
of pregnancy-associated plasma protein-A is associated with
resistance to atherosclerotic lesion development in apolipoprotein
E-deficient
mice challenged with a high-fat diet.
Authors: Harrington SC, Simari RD, Conover CA.
Journal: Circ Res. 2007 Jun 22;100(12):1696-702.
Epub 2007 May 17.
View Abstract
Hereditary
and environmental influences on arterial function.
Authors: Hayward CS, Benetos A.
Journal: Clin Exp
Pharmacol Physiol. 2007 Jul;34(7):658-64. Review.
View Abstract
Vascular
stiffness and genetic variation at the endothelial nitric oxide
synthase locus: the Framingham Heart study.
Authors: Mitchell GF, Guo CY, Kathiresan S, Vasan RS, Larson
MG, Vita JA, Keyes MJ, Vyas M, Newton-Cheh C, Musone SL, Camargo
AL,
Drake JA, Levy D, O'Donnell CJ, Hirschhorn JN, Benjamin EJ.
Journal: Hypertension. 2007
Jun;49(6):1285-90. Epub 2007 Apr 2.
View Abstract
Frequency of paraoxonase 192/55 polymorphism in an Iranian population.
Authors: Sepahvand F, Rahimi-Moghaddam P, Shafiei M, Ghaffari SM, Rostam-Shirazi M, Mahmoudian M.
Journal: J Toxicol Environ Health A. 2007 Jul;70(13):1125-9.
View Abstract
Effects of the renin-angiotensin system genes and salt sensitivity genes on blood pressure and atherosclerosis in the total population and patients with type 2 diabetes.
Authors: Yazdanpanah M, Aulchenko YS, Hofman A, Janssen JA, Sayed-Tabatabaei FA, van Schaik RH, Klungel OH, Stricker BH, Pols HA, Witteman JC, Lamberts SW, Oostra BA, van Duijn CM.
Journal: Diabetes. 2007 Jul;56(7):1905-12. Epub 2007 Apr 19.
View Abstract
The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study.
Authors: Isaacs A, Sayed-Tabatabaei FA, Hofman A, Oostra BA, Klungel OH, Maitland-Vander Zee AH, Stricker BH, Witteman JC, van Duijn CM.
Journal: Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):419-21.
View Abstract
Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the atherosclerosis risk in communities study.
Authors: Volcik K, Ballantyne CM, Pownall HJ, Sharrett AR, Boerwinkle E.
Journal: J Stud Alcohol Drugs. 2007 Jul;68(4):485-92.
View Abstract
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.
Authors: Norata GD, Ongari M, Garlaschelli K, Tibolla G, Grigore L, Raselli S, Vettoretti S, Baragetti I, Noto D, Cefalu AB, Buccianti G, Averna M, Catapano AL.
Journal: J Intern Med. 2007 Jul;262(1):104-12.
View Abstract
Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality.
Marz W, Seelhorst U, Wellnitz B, Tiran B, Obermayer-Pietsch B, Renner W, Boehm BO, Ritz E, Hoffmann MM.
J Clin Endocrinol Metab. 2007 Jun;92(6):2363-9. Epub 2007 Mar 20.
View Abstract |
Back to Top
Imaging |
Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron
emission
tomography. Pilot study.
Authors: Arauz A, Hoyos L, Zenteno M, Mendoza R, Alexanderson
E.
Journal: Clin Neurol Neurosurg. 2007 Jun;109(5):409-12. Epub 2007 Apr 5.
View Abstract
Imaging techniques for the vulnerable coronary plaque.
Authors: Cademartiri F, La Grutta L, Palumbo A, Maffei E, Aldrovandi
A, Malago R, Alberghina F, Pugliese F, Runza G, Belgrano M, Midiri
M, Cova MA, Krestin GP.
Journal: Radiol Med (Torino). 2007 Jul 24; [Epub ahead of print]
View Abstract
Increased echolucency of carotid plaques in patients
with type 2 diabetes.
Authors: Ostling G, Hedblad B, Berglund
G, Goncalves I.
Journal: Stroke. 2007 Jul;38(7):2074-8. Epub 2007 May 24.
View
Abstract
Association of high-density lipoprotein levels
and carotid atherosclerotic plaque characteristics by magnetic resonance
imaging.
Authors: Phan BA, Chu B, Polissar N, Hatsukami TS, Yuan C, Zhao
XQ.
Journal: Int J Cardiovasc Imaging. 2007 Jun;23(3):337-42. Epub
2006 Nov 4.
View Abstract
Identification of atherosclerotic lipid deposits by diffusion-weighted
imaging.
Authors: Qiao Y, Ronen I, Viereck J, Ruberg FL, Hamilton JA.
Journal: Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1440-6.
Epub 2007
Mar 22.
View Abstract
MDCT angiography of the renal arteries in patients
with atherosclerotic renal artery stenosis: implications for
renal artery stenting with distal protection.
Authors: Talenfeld AD, Schwope RB,
Alper HJ, Cohen EI, Lookstein RA.
Journal: AJR Am J Roentgenol. 2007 Jun;188(6):1652-8.
View
Abstract
The topography of aortic atherosclerosis
enhances its precision as a predictor of stroke.
Authors: van der Linden J, Bergman P,
Hadjinikolaou L.
Journal: Ann Thorac Surg. 2007 Jun;83(6):2087-92.
View
Abstract |
Back to Top
Immunology |
Enhanced
immune system activation and arterial inflammation accelerates
atherosclerosis in lupus-prone mice.
Authors: Gautier EL, Huby T, Ouzilleau B, Doucet C,
Saint-Charles F, Gremy G, Chapman MJ, Lesnik P.
Journal: Arterioscler Thromb
Vasc Biol. 2007 Jul;27(7):1625-31. Epub 2007 Apr 19.
View Abstract
Mast cells: multipotent local effector
cells in atherothrombosis.
Authors: Kovanen PT.
Journal: Immunol Rev. 2007 Jun;217:105-22.
Review.
View Abstract
Basic science for the clinician 44: atherosclerosis:
an immunologically mediated (autoimmune?) disease.
Author: Sigal LH.
Journal: J Clin Rheumatol.
2007 Jun;13(3):160-8.
Review.
View Abstract
Accumulation of
immune cells and high expression of chemokines/chemokine
receptors in the upstream shoulder of atherosclerotic
carotid plaques.
Authors: Yilmaz A, Lipfert B, Cicha I, Schubert K, Klein M, Raithel
D, Daniel WG, Garlichs CD.
Journal: Exp Mol Pathol. 2007 Jun;82(3):245-55. Epub 2007
Jan 12
View Abstract |
Back to Top
Inflammation |
Postprandial inflammation and endothelial dysfuction.
Authors: Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Cabezas
MC.
Journal: Biochem Soc Trans. 2007 Jun;35(Pt 3):466-9.
View Abstract
Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron
emission tomography. Pilot study.
Authors: Arauz A, Hoyos L, Zenteno M, Mendoza R, Alexanderson
E.
Journal: Clin Neurol Neurosurg. 2007 Jun;109(5):409-12. Epub
2007 Apr 5.
View Abstract
Delta-like 4 induces notch signaling in macrophages:
implications for inflammation.
Authors: Fung E, Tang SM, Canner JP, Morishige K, Arboleda-Velasquez JF, Cardoso
AA, Carlesso N, Aster JC, Aikawa M.
Journal: Circulation. 2007 Jun 12;115(23):2948-56. Epub 2007 May 28.
View
Abstract Enhanced immune system activation and arterial inflammation
accelerates atherosclerosis in lupus-prone mice.
Authors: Gautier EL, Huby T, Ouzilleau B, Doucet C, Saint-Charles F, Gremy
G, Chapman MJ, Lesnik P.
Journal: Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1625-31. Epub 2007 Apr
19.
View
Abstract
Endotoxin-induced effects on platelets and monocytes
in an in vivo model of inflammation.
Authors: Kalsch T, Elmas E, Nguyen XD, Suvajac N, Kluter H, Borggrefe
M, Dempfle CE.
Journal: Basic Res Cardiol. 2007 Jul 13; [Epub ahead of print]
View Abstract
Platelets, inflammation and atherosclerosis.
Authors: Lindemann S, Kramer B, Seizer P, Gawaz M.
Journal: J Thromb Haemost. 2007 Jul;5 Suppl 1:203-11.
View Abstract
Signal transducer of inflammation gp130 modulates
atherosclerosis in mice and man.
Authors: Luchtefeld M, Schunkert H, Stoll M, Selle T, Lorier
R, Grote K, Sagebiel C, Jagavelu K, Tietge UJ, Assmus U, Streetz
K, Hengstenberg
C, Fischer M, Mayer B, Maresso
K, El Mokhtari NE, Schreiber S, Muller W, Bavendiek U, Grothusen C,
Drexler H, Trautwein C, Broeckel U, Schieffer B.
Journal: J Exp Med. 2007 Jul 30; [Epub ahead of print]
View Abstract
Left ventricular hypertrophy, subclinical atherosclerosis,
and inflammation.
Authors: Mehta SK, Rame JE, Khera A, Murphy SA, Canham RM, Peshock
RM, de Lemos JA, Drazner MH.
Journal: Hypertension. 2007 Jun;49(6):1385-91. Epub 2007 Apr
2.
View Abstract
Both cyclooxygenase-
and cytokine-mediated inflammation are
associated with carotid intima-media thickness.
Authors: Wohlin M, Helmersson J, Sundstrom J, Arnlov
J, Vessby B, Larsson A, Andren B, Lind L, Basu S.
Journal: Cytokine. 2007 Jul 16; [Epub ahead of print]
View Abstract |
Back to Top
Lipid and Lipoprotein Metabolism |
Regulation
of protein C inhibitor (PCI) activity by specific oxidized
and negatively charged phospholipids.
Authors: Malleier JM, Oskolkova O, Bochkov V, Jerabek I, Sokolikova
B, Perkmann T, Breuss J, Binder BR, Geiger M.
Journal: Blood. 2007 Jun 1;109(11):4769-76.
Epub 2007 Mar 1.
View Abstract
Intestinal cholesterol
transport
proteins: an update and beyond.
Authors: Levy E, Spahis S, Sinnett D, Peretti N, Maupas-Schwalm
F, Delvin E, Lambert M, Lavoie MA.
Journal: Curr Opin Lipidol.
2007 Jun;18(3):310-8.
Review.
View Abstract
Bile
acids, farnesoid X receptor, atherosclerosis and
metabolic control. Kuipers F, Stroeve JH, Caron S, Staels B.
Curr Opin Lipidol.
2007 Jun;18(3):289-97. Review.
View Abstract |
Back to Top
Lipidomics |
Developmental changes in rat
surfactant lipidomics in the context of species variability.
Authors: Bernhard W, Schmiedl A, Koster G, Orgeig S, Acevedo
C, Poets CF, Postle AD.
Journal: Pediatr Pulmonol. 2007 Jul 20;42(9):794-804 [Epub
ahead of print]
View
Abstract
Adipose tissue inflammation and increased ceramide content
characterize subjects with high liver fat content independent
of obesity.
Authors: Kolak M, Westerbacka J, Velagapudi VR, Wagsater D,
Yetukuri L, Makkonen J, Rissanen A, Hakkinen AM, Lindell M,
Bergholm
R, Hamsten A, Eriksson P, Fisher RM, Oresic M, Yki-Jarvinen
H.
Journal: Diabetes. 2007 Aug;56(8):1960-8. Epub 2007 Jul
9.
View
Abstract
Top-down
lipidomic screens by multivariate analysis of high-resolution
survey mass spectra.
Authors: Schwudke D, Hannich JT, Surendranath V, Grimard V,
Moehring T, Burton L, Kurzchalia T, Shevchenko A.
Journal: Anal Chem. 2007 Jun 1;79(11):4083-93.
Epub 2007 May 3.
View
Abstract
Exploring the lipoprotein composition using Bayesian regression
on serum lipidomic profiles.
Authors: Sysi-Aho M, Vehtari A, Velagapudi VR, Westerbacka
J, Yetukuri L, Bergholm R, Taskinen MR, Yki-Jarvinen H, Oresic
M.
Journal: Bioinformatics. 2007 Jul 1;23(13):i519-i528.
View
Abstract |
Back to Top
Menopause
|
Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis.
Authors: Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, Heigl A, Lachat M, Genoni M, Barton M.
Journal: Hypertension. 2007 Jun;49(6):1358-63. Epub 2007 Apr 23.
View Abstract Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal women.
Authors: Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A.
Journal: Diabetes Res Clin Pract. 2007 Jun;76(3):378-82. Epub 2006 Oct 10.
View Abstract
Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis.
Authors: Vigen C, Hodis HN, Chandler WL, Lobo RA, Mack WJ.
Journal: J Thromb Haemost. 2007 Jun;5(6):1201-8.
View Abstract |
Back to Top
Metabolic Syndrome |
Metabolic
syndrome is not associated with markers of subclinical atherosclerosis,
serum adiponectin and endogenous androgen concentrations
in Japanese men with Type 2 diabetes.
Authors: Fukui M, Ose H, Kitagawa
Y, Kamiuchi K, Nakayama I, Ohta M, Obayashi H, Yamasaki M, Hasegawa
G, Yoshikawa T, Nakamura N.
Journal: Diabet Med. 2007 Jun 25; [Epub ahead of print]
View
Abstract The effects of metabolic syndrome versus
infectious burden on inflammation, severity of coronary atherosclerosis,
and major adverse cardiovascular events.
Authors: Dai DF, Lin JW, Kao JH, Hsu
CN, Chiang FT, Lin JL, Chou YH, Hsu KL, Tseng CD, Tseng YZ, Hwang
JJ.
Journal: J Clin Endocrinol Metab. 2007 Jul;92(7):2532-7. Epub 2007 Apr 10.
View
Abstract |
Back to Top
Nutrition
and Diet |
Associations between markers of subclinical atherosclerosis and dietary patterns derived by principal components analysis and reduced rank regression in the Multi-Ethnic Study of Atherosclerosis (MESA).
Authors: Nettleton JA, Steffen LM, Schulze MB, Jenny NS, Barr RG, Bertoni AG, Jacobs DR Jr.
Journal: Am J Clin Nutr. 2007 Jun;85(6):1615-25.
View Abstract
Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice.
Authors: Bell TA 3rd, Kelley K, Wilson MD, Sawyer JK, Rudel LL. Journal: Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1396-402. Epub 2007 Apr 12.
View Abstract
Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient mice.
Authors: Harauma A, Murayama T, Ikeyama K, Sano H, Arai H, Takano R, Kita T, Hara S, Kamei K, Yokode M.
Journal: Biochem Biophys Res Commun. 2007 Jul 6;358(3):751-6. Epub 2007 May 7.
View Abstract
Whole-grain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study.
Authors: Mellen PB, Liese AD, Tooze JA, Vitolins MZ, Wagenknecht LE, Herrington DM.
Journal: Am J Clin Nutr. 2007 Jun;85(6):1495-502.
View Abstract
L-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits.
Authors: Rasmusen C, Moinard C, Martin C, Tricottet V, Cynober L, Couderc R.
Journal: Br J Nutr. 2007 Jun;97(6):1083-9. Epub 2007 Mar 29.
View Abstract
Overview of dietary influences on atherosclerotic vascular disease: epidemiology and prevention.
Authors: Thomas GN, Cheung BM, Ho SY, Macfarlane DJ, Deng HB, McGhee SM, Woo J, Lam TH, Tomlinson B.
Journal: Cardiovasc Hematol Disord Drug Targets. 2007 Jun;7(2):87-97. Review.
View Abstract
Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice.
Authors: Saraswathi V, Gao L, Morrow JD, Chait A, Niswender KD, Hasty AH.
Journal: J Nutr. 2007 Jul;137(7):1776-82.
View Abstract
Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients.
Rodriguez M, Ringstad L, Schafer P, Just S, Hofer HW, Malmsten M, Siegel G.
Atherosclerosis. 2007 Jun;192(2):438-44. Epub 2007 Mar 29.
View Abstract |
Back to Top
Oxidative Stress / Antioxidants |
Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: Effect of ascorbic acid.
Authors: Cangemi R, Angelico F, Loffredo L, Del Ben M, Pignatelli P, Martini A, Violi F.
Journal: Free Radic Biol Med. 2007 Sep 1;43(5):853-9. Epub 2007 Jun 13.
View Abstract Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior.
Authors: Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH.
Journal: J Am Coll Cardiol. 2007 Jun 26;49(25):2379-93. Epub 2007 Jun 8. Review.
View Abstract
Reactive carbonyls and oxidative stress: Potential for therapeutic intervention.
Author: Ellis EM.
Journal: Pharmacol Ther. 2007 Jul;115(1):13-24. Epub 2007 May 8.
View Abstract
Effect of Pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients.
Authors: Maiti R, Agrawal NK, Dash D, Pandey BL.
Journal: Vascul Pharmacol. 2007 Aug-Sep;47(2-3):118-24. Epub 2007 Jun 2.
View Abstract
Gone with the Wnts: {beta}-catenin, TCF, FOXO, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism.
Authors: Manolagas SC, Almeida M.
Journal: Mol Endocrinol. 2007 Jul 10; [Epub ahead of print]
View Abstract
Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors.
Authors: Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R.
Journal: Br J Pharmacol. 2007 Jul 23; [Epub ahead of print]
View Abstract
Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis.
Authors: Orozco LD, Kapturczak MH, Barajas B, Wang X, Weinstein MM, Wong J, Deshane J, Bolisetty S, Shaposhnik Z, Shih DM, Agarwal A, Lusis AJ, Araujo JA.
Journal: Circ Res. 2007 Jun 22;100(12):1703-11. Epub 2007 May 10.
View Abstract
Mechanisms for oxidative stress in diabetic cardiovascular disease.
Authors: Pennathur S, Heinecke JW.
Journal: Antioxid Redox Signal. 2007 Jul;9(7):955-69.
View Abstract
Native C-reactive protein induces endothelial dysfunction in ApoE(-/-) mice: Implications for iNOS and reactive oxygen species.
Authors: Schwedler SB, Kuhlencordt PJ, Ponnuswamy PP, Hatiboglu G, Quaschning T, Widder J, Wanner C, Potempa LA, Galle J.
Journal: Atherosclerosis. 2007 Jul 30; [Epub ahead of print]
View Abstract
Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice.
Authors: Sugita M, Sugita H, Kaneki M.
Journal: Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1390-5. Epub 2007 Mar 15.
View Abstract
Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress.
Authors: Tang F, Wu X, Wang T, Wang P, Li R, Zhang H, Gao J, Chen S, Bao L, Huang H, Liu P.
Journal: Vascul Pharmacol. 2007 Jun;46(6):427-38. Epub 2007 Jan 23.
View Abstract
Atherosclerosis and Oxidant Stress: The End of the Road for Antioxidant Vitamin Treatment?
Thomson MJ, Puntmann V, Kaski JC.
Cardiovasc Drugs Ther. 2007 Jun;21(3):195-210.
View Abstract
Both cyclooxygenase- and cytokine-mediated inflammation are associated with carotid intima-media thickness.
Wohlin M, Helmersson J, Sundstrom J, Arnlov J, Vessby B, Larsson A, Andren B, Lind L, Basu S.
Cytokine. 2007 Jul 16; [Epub ahead of print]
View Abstract
Anti-oxidant and anti-atherogenic properties of liposomal glutathione: Studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice.
Authors: Rosenblat M, Volkova N, Coleman R, Aviram M.
Journal: Atherosclerosis. 2007 Jun 21; [Epub ahead of print]
View Abstract
Increased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice.
Authors: Qiao M, Kisgati M, Cholewa JM, Zhu W, Smart EJ, Sulistio MS, Asmis R.
Journal: Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1375-82. Epub 2007 Mar 15.
View Abstract
Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice.
Authors: Sugita M, Sugita H, Kaneki M.
Journal: Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1390-5. Epub 2007
Mar 15.
View Abstract |
Back to Top
Pediatrics |
Traditional and "new" cardiovascular risk markers and factors in pediatric dialysis patients.
Authors: Civilibal M, Caliskan S, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Bugra Z, Arisoy N.
Journal: Pediatr Nephrol. 2007 Jul;22(7):1021-9. Epub 2007 Mar 6.
View Abstract
Age of onset of type 1 diabetes in children and carotid intima medial thickness.
Authors: Dalla Pozza R, Bechtold S, Bonfig W, Putzker S, Kozlik-Feldmann R, Netz H, Schwarz HP.
Journal: J Clin Endocrinol Metab. 2007 Jun;92(6):2053-7. Epub 2007 Mar 20.
View Abstract
Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schonlein purpura.
Authors: Ece A, Kelekci S, Kocamaz H, Hekimoglu A, Balik H, Yolbas I, Erel O.
Journal: Clin Rheumatol. 2007 Jul 24; [Epub ahead of print]
View Abstract
Statin Treatment in Children With Familial Hypercholesterolemia. The Younger, the Better.
Authors: Rodenburg J, Vissers MN, Wiegman A, van Trotsenburg AS, van der Graaf A, de Groot E, Wijburg FA, Kastelein JJ, Hutten BA.
Journal: Circulation. 2007 Jul 30; [Epub ahead of print]
View Abstract
Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia.
Authors: Schwab KO, Doerfer J, Krebs A, Krebs K, Schorb E, Hallermann K, Superti-Furga A, Zieger B, Marz W, Schmidt-Trucksass A, Winkler K.
Journal: Eur J Pediatr. 2007 Jun;166(6):541-8. Epub 2007 Mar 27.
View Abstract |
Back to Top
Plaque Biology |
Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry.
Authors: Bagnato C, Thumar J, Mayya V, Hwang SI, Zebroski H, Claffey KP, Haudenschild C, Eng JK, Lundgren DH, Han DK.
Journal: Mol Cell Proteomics. 2007 Jun;6(6):1088-102. Epub 2007 Mar 5.
View Abstract
Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque.
Authors: Canet-Soulas E, Letourneur D.
Journal: MAGMA. 2007 Jun;20(3):129-42. Epub 2007 Jun 29.
View Abstract
Chlamydia pneumoniae and symptomatic carotid atherosclerotic plaque: a prospective study.
Authors: Gagliardi RJ, Silveira DR, Caffaro RA, dos Santos VP, Caiaffa-Filho HH.
Journal: Arq Neuropsiquiatr. 2007 Jun;65(2B):385-9.
View Abstract
Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia--implications for vulnerable plaque-development.
Authors: Gossl M, Versari D, Mannheim D, Ritman EL, Lerman LO, Lerman A.
Journal: Atherosclerosis. 2007 Jun;192(2):246-52. Epub 2006 Aug 21.
View Abstract
Plaque progression and regression in atherothrombosis.
Authors: Ibanez B, Vilahur G, Badimon JJ.
Journal: J Thromb Haemost. 2007 Jul;5 Suppl 1:292-9.
View Abstract
The expression of vascular dendritic cells in human atherosclerotic carotid plaques.
Authors: Kawahara I, Kitagawa N, Tsutsumi K, Nagata I, Hayashi T, Koji T.
Journal: Hum Pathol. 2007 Jun 5; [Epub ahead of print]
View Abstract
Inhibition of Progression and Stabilization of Plaques by Postnatal Interferon-{gamma} Function Blocking in ApoE-Knockout Mice.
Authors: Koga M, Kai H, Yasukawa H, Yamamoto T, Kawai Y, Kato S, Kusaba K, Kai M, Egashira K, Kataoka Y, Imaizumi T.
Journal: Circ Res. 2007 Jul 5; [Epub ahead of print]
View Abstract
Pathological mechanisms of erythrocyte-induced vulnerability of atherosclerotic plaques.
Authors: Lin HL, Xu XS, Lu HX, Li CJ, Tang MX, Sun HW, Zhang Y.
Journal: Med Hypotheses. 2007 Jun 28; [Epub ahead of print]
View Abstract
Influence of Residual Stress/Strain on the Biomechanical Stability of Vulnerable Coronary Plaques: Potential Impact for Evaluating the Risk of Plaque Rupture.
Authors: Ohayon J, Dubreuil O, Tracqui P, Le Floc'h S, Rioufol G, Chalabreysse L, Thivolet F, Pettigrew R, Finet G.
Journal: Am J Physiol Heart Circ Physiol. 2007 Jun 29; [Epub ahead of print]
View Abstract
Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging.
Authors: Phan BA, Chu B, Polissar N, Hatsukami TS, Yuan C, Zhao XQ.
Journal: Int J Cardiovasc Imaging. 2007 Jun;23(3):337-42. Epub 2006 Nov 4.
View Abstract
Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI).
Authors: Smith BR, Heverhagen J, Knopp M, Schmalbrock P, Shapiro J, Shiomi M, Moldovan NI, Ferrari M, Lee SC.
Journal: Biomed Microdevices. 2007 Jun 12; [Epub ahead of print]
View Abstract
|
Back to Top
Renal Disease |
Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function.
Authors: Addabbo F, Mallamaci F, Leonardis D, Tripepi R, Tripepi G, Goligorsky MS, Zoccali C.
Journal: Nephrol Dial Transplant. 2007 Jul 21; [Epub ahead of print]
View Abstract
Cardiovascular disease and subsequent kidney disease.
Authors: Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, Sarnak MJ, Weiner DE.
Journal: Arch Intern Med. 2007 Jun 11;167(11):1130-6.
View Abstract
Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury.
Authors: Okamura DM, Lopez-Guisa JM, Koelsch K, Collins S, Eddy AA.
Journal: Am J Physiol Renal Physiol. 2007 Aug;293(2):F575-85. Epub 2007 May 30.
View Abstract
Chronic kidney disease: effects on the cardiovascular system.
Authors: Schiffrin EL, Lipman ML, Mann JF.
Journal: Circulation. 2007 Jul 3;116(1):85-97. Review.
View Abstract |
Back to Top
Risk
Factors
|
Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study.
Authors: Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, Kuller LH, Cushman M
Journal: Circulation. 2007 Jul 3;116(1):32-8. Epub 2007 Jun 18.
View Abstract
Tobacco smoke exposure is associated with attenuated endothelial function in 11-year-old healthy children.
Kallio K, Jokinen E, Raitakari OT, Hamalainen M, Siltala M, Volanen I, Kaitosaari T, Viikari J, Ronnemaa T, Simell O.
Circulation. 2007 Jun 26;115(25):3205-12. Epub 2007 Jun 4.
View Abstract
Resialylation of sialic acid deficit vascular endothelium, circulating cells and macromolecules may counteract the development of atherosclerosis: a hypothesis.
Lindberg G.
Atherosclerosis. 2007 Jun;192(2):243-5. Epub 2007 Apr 8.
View Abstract
Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis.
Orozco LD, Kapturczak MH, Barajas B, Wang X, Weinstein MM, Wong J, Deshane J, Bolisetty S, Shaposhnik Z, Shih DM, Agarwal A, Lusis AJ, Araujo JA.
Circ Res. 2007 Jun 22;100(12):1703-11. Epub 2007 May 10.
View Abstract
Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism.
Prasad K, Lee P.
Atherosclerosis. 2007 Jun;192(2):313-22. Epub 2006 Sep 11.
View Abstract
Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?
Wilund KR.
Clin Sci (Lond). 2007 Jun;112(11):543-55. Review.
View Abstract |
Back to Top
Stroke |
Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: A prospective analysis of the Women's Health Study.
Albert MA, Glynn RJ, Buring JE, Ridker PM.
Atherosclerosis. 2007 Jul 17; [Epub ahead of print]
View Abstract
Carotid Plaque, Stroke Pathogenesis, and CRP: Treatment of Ischemic Stroke.
Krupinski J, Turu MM, Slevin M, Martinez-Gonzalez J.
Curr Treat Options Cardiovasc Med. 2007 Jun;9(3):229-235.
View Abstract
|
Back to Top
Vascular Biology |
Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
Authors: Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, Satoh H, Inoue K, Kawase Y, Jishage K, Suzuki H, Takeya M, Schnackenberg L, Beger R, Hermonat PL, Thomas M, Sawamura T.
Journal: Circ Res. 2007 Jun 8;100(11):1634-42. Epub 2007 May 3.
View Abstract
Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice.
Authors: Ng CJ, Bourquard N, Hama SY, Shih D, Grijalva VR, Navab M, Fogelman AM, Reddy ST.
Journal: Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1368-74. Epub 2007 Apr 19.
View Abstract
Grb2 is required for atherosclerotic lesion formation.
Authors: Proctor BM, Ren J, Chen Z, Schneider JG, Coleman T, Lupu TS, Semenkovich CF, Muslin AJ.
Journal: Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1361-7. Epub 2007
Mar 15.
View Abstract
|
Back to Top
Vascular Calcification / Calcium Signaling |
The good and the bad in the link between insulin resistance and vascular calcification.
Fadini GP, Pauletto P, Avogaro A, Rattazzi M.
Atherosclerosis. 2007 Aug;193(2):241-4. Epub 2007 Jul 2.
View Abstract
Relation of aortic valve calcium to myocardial ischemic perfusion in individuals with a low coronary artery calcium score.
Ho J, FitzGerald S, Cannaday J, Stolfus L, Weilbacher D, Henderson Y, Newman T, Whitehead R, Radford N.
Am J Cardiol. 2007 Jun 1;99(11):1535-7. Epub 2007 Apr
View Abstract
High-normal fasting blood glucose in non-diabetic range is associated with increased coronary artery calcium burden in asymptomatic men.
Nasir K, Santos RD, Tufail K, Rivera J, Carvalho JA, Meneghello R, Brady TD, Blumenthal RS.
Atherosclerosis. 2007 Jun 30; [Epub ahead of print]
View Abstract
Metabolic syndrome is associated with coronary artery calcium in asymptomatic white Brazilian men considered low-risk by Framingham risk score.
Santos RD, Nasir K, Tufail K, Meneghelo RS, Carvalho JA, Blumenthal RS. Prev Cardiol. 2007 Summer;10(3):141-6.
View Abstract |
|
